Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion type Assertion NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_head.
- NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion description "[To evaluate how the angiogenetic biomarkers vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and interleukin-8 (IL-8) in the fluid of non-small cell lung cancer (NSCLC) with malignant pleural effusion (MPE) correlate with patient survival and pleural effusion control.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_provenance.
- NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion evidence source_evidence_literature NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_provenance.
- NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion SIO_000772 19157636 NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_provenance.
- NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion wasDerivedFrom befree-20140225 NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_provenance.
- NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_assertion wasGeneratedBy ECO_0000203 NP206628.RAn9fOfmUCY5aHUu_2gvCmt2ZSdhylorXnd9_pkSS50Eo130_provenance.